Cash Flows from Operating Activities | |
Net income | 1.44B |
Adjustments to reconcile net income to net cash provided by operating activities | |
Depreciation | |
Amortization of recoverable transition costs and other | |
Deferred income taxes and investment tax credits | 436M |
Gains related to the extinguishment of notes | |
Impairment of assets | |
Unrealized (gains) losses on derivatives and other hedging activities | 107M |
Other | |
Change in current assets and current liabilities | |
Accounts receivable | |
Accounts payable | -40M |
Unbilled revenue | 32M |
Fuel, materials and supplies | 8M |
Prepayments | -34M |
Taxes | |
Counterparty collateral deposits | |
Price risk management assets and liabilities | |
Other | -21M |
Other operating activities | |
Other assets | 18M |
Other liabilities | -75M |
Net cash provided by operating activities | 2.23B |
Cash Flows from Investing Activities | |
Expenditures for property, plant and equipment | -2.07B |
Expenditures for intangible assets | -23M |
Proceeds from the sale of intangible assets | |
Purchases of nuclear plant decommissioning trust investments | |
Proceeds from the sale of nuclear plant decommissioning trust investments | |
Purchases of other investments | |
Proceeds from the sale of other investments | 2M |
Net (increase) decrease in restricted cash and cash equivalents | |
Other investing activities | 28M |
Net cash used in investing activities | -2.07B |
Cash Flows from Financing Activities | |
Issuance of long-term debt | 1.24B |
Issuance of common stock | 133M |
Retirement of long-term debt | -905M |
Repurchase of common stock due to the repurchase program | |
Payment of common stock dividends | -772M |
Net increase (decrease) in short-term debt | -268M |
Other financing activities | -33M |
Net cash provided by (used in) financing activities | -558M |
Effect of Exchange Rates on Cash and Cash Equivalents | -26M |
Net Increase (Decrease) in Cash and Cash Equivalents | -11M |
Cash and Cash Equivalents at Beginning of Period | 836M |
Cash and Cash Equivalents included in Assets Held for Sale | |
Cash and Cash Equivalents at End of Period | 416M |